AGT and diabetes mellitus: An elegant study by Benter and colleagues [50] suggested that treatment with Ang-(1-7) and/or the Ang-(1–7) receptor MasR agonist AVE-0991 reduces albuminuria and abrogates the diabetes-induced abnormal vascular responsiveness to norepinephrine, endothelin-1, and Ang II.